Rosuvastatin Not Yet Recruiting Phase 3 Trials for Dyslipidemias Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03540355Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment